Rh negative mother, ICT negative was given Anti D at 28 week of pregnancy. Which of the following is the follow up schedule?
**Core Concept**
Rh incompatibility between mother and fetus can lead to hemolytic disease of the newborn (HDN), where maternal antibodies against fetal RhD antigen can cause hemolysis. Anti-D immunoglobulin is administered to Rh-negative mothers to prevent this by neutralizing any fetal RhD antigen that may enter the maternal circulation during pregnancy or delivery.
**Why the Correct Answer is Right**
The administration of Anti-D immunoglobulin at 28 weeks of pregnancy is a preventive measure to reduce the risk of HDN. To further ensure the prevention of HDN, another dose of Anti-D immunoglobulin should be administered within 72 hours postpartum, depending on the baby's blood group and direct Coombs test (DCT) results. This is because the baby may still be Rh-positive, and the maternal antibodies may have already formed. Administering Anti-D immunoglobulin postpartum helps to neutralize these antibodies and prevent HDN. The timing of 72 hours postpartum is crucial, as it allows for the assessment of the baby's blood group and DCT results.
**Why Each Wrong Option is Incorrect**
**Option B:** Giving another dose of Anti-D immunoglobulin 72 hours postpartum irrespective of the baby's blood group is incorrect because it does not take into account the baby's potential RhD status and the presence of maternal antibodies.
**Option C:** Anti-D immunoglobulin has a direct effect on the status of the indirect Coombs test (ICT), not the indirect Coombs test itself. ICT is used to detect the presence of maternal antibodies against fetal RhD antigen, and Anti-D immunoglobulin can alter the results of ICT.
**Option D:** Administering the next dose of Anti-D immunoglobulin at 34 weeks is incorrect because it is not based on any clinical guidelines or recommendations for postpartum administration of Anti-D immunoglobulin.
**Clinical Pearl / High-Yield Fact**
It is essential to remember that the administration of Anti-D immunoglobulin is not a one-time event but rather a part of a comprehensive strategy to prevent HDN. The timing and dosing of Anti-D immunoglobulin are critical, and healthcare providers must carefully consider the baby's blood group and DCT results when making decisions about postpartum administration.
✓ Correct Answer: A. Give another dose of Anti D within 72 hour postpaum depending on the baby blood group and DCT